DeutschNewstral
Article
Fft.com on 2019-10-22 13:42
Biogen to seek Alzheimer’s drug approval
Related news
House investigation faults FDA, Biogen for Alzheimer’s drug approvalpost-gazette.com- FApproval of Biogen Alzheimer’s drug reignites ‘amyloid’ debateft.com
Congress faults US regulator’s approval of Biogen Alzheimer’s drugFinancial Times
Biogen cuts Alzheimer’s drug price 50% months after approvalSeattle Times
FTC demands Alzheimer’s drug approval, marketing information from Biogenbizjournals.com- FBiogen predicts preventive Alzheimer’s drugft.com
- FFDA approves Biogen Alzheimer’s drugft.com
- Biogen plans to shut down its controversial Alzheimer’s drug AduhelmSeattle Times
Eli Lilly to seek FDA approval for Alzheimer’s drug that firm says slows cognitive declineAlaska Dispatch News
Eisai and Biogen apply for approval of Alzheimer’s drug in JapanThe Japan Times
FDA Commissioner Calls For Inspector General Probe Into Biogen Alzheimer’s Drug ApprovalForbes- BAfter Lengthy Delay, Biogen Submits Troubled Alzheimer’s Drug for FDA Approvalbarrons.com
- BBiogen Is Spiking Because Its Alzheimer’s Drug Takes Another Step Toward Approvalbarrons.com
- In reversal, Biogen to file for approval of Alzheimer's drugbizjournals.com
Panels find FDA, Biogen rushed Alzheimer’s drugArkansas Online
Biogen Abandons Its Controversial Alzheimer’s Drug AduhelmThe New York Times
Biogen Alzheimer’s Drug Impresses in Early Studywsj.com